EFFICACY OF PREVENTING RELAPSE EVALUATED BY A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, WITHDRAWAL STUDY OF ESCITALOPRAM IN JAPANESE ADOLESCENTS WITH MDD

被引:0
|
作者
Saito, Takuya [1 ]
Takahashi, Hidetoshi [1 ]
Tujii, Noa [1 ]
机构
[1] Hokkaido Univ, Sapporo, Hokkaido, Japan
关键词
D O I
10.1016/j.jaac.2023.09.511
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
引用
收藏
页码:S319 / S319
页数:1
相关论文
共 50 条
  • [1] Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder
    Saito, Takuya
    Takahashi, Hidetoshi
    Tsujii, Noa
    Sasaki, Tsuyoshi
    Yamaguchi, Yuta
    Takatsu, Masahiro
    Sato, Masaki
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (10) : 418 - 427
  • [2] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [3] Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    Schroeder, Heidi
    Mossman, Sarah A.
    Varney, Sara T.
    Ramsey, Laura B.
    Poweleit, Ethan A.
    Desta, Zeruesenay
    Cecil, Kim
    DelBello, Melissa P.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [4] A MULTICENTER DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ESCITALOPRAM IN CHILDREN AND ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER
    Strawn, Jeffrey Robert
    Moldauer, Leslie
    Hahn, Rebekah D.
    Wise, Alexandria
    Bertzos, Kristina
    Eisenberg, Beth
    Greenberg, Edward F.
    Liu, Chengcheng
    Gopalkrishnan, Mallika
    Mcvoy, Molly
    Knutson, James A.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S185 - S185
  • [5] A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder
    Strawn, Jeffrey R.
    Moldauer, Leslie
    Hahn, Rebekah D.
    Wise, Alexandria
    Bertzos, Kristina
    Eisenberg, Beth
    Greenberg, Edward
    Liu, Chengcheng
    Gopalkrishnan, Mallika
    McVoy, Molly
    Knutson, James A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (03) : 91 - 100
  • [6] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [7] Oxcarbazepine -: Efficacy and tolerability during treatment of alcohol withdrawal:: A double-blind, randomized, placebo-controlled multicenter pilot study
    Koethe, Dagmar
    Juelicher, Antje
    Nolden, Brit M.
    Braunwarth, Wolf-Dietrich
    Klosterkoetter, Joachim
    Niklewski, Guenter
    Wodarz, Norbert
    Klatt, Jan
    Burtscheidt, Wilhelm
    Gaebel, Wolfgang
    Leweke, F. Markus
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (07) : 1188 - 1194
  • [8] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154
  • [9] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, Rajiv
    Loebel, Antony
    Phillips, Debra
    Pikalov, Andrei
    Hernandez, David
    Mao, Yongcai
    Cucchiaro, Josephine
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S372 - S372
  • [10] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, Rajiv
    Cucchiaro, Josephine
    Phillips, Debra
    Hernandez, David
    Mao, Yongcai
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 69 - 77